These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 7812948

  • 1. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1995 Jan 15; 55(2):224-7. PubMed ID: 7812948
    [Abstract] [Full Text] [Related]

  • 2. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW.
    Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029
    [Abstract] [Full Text] [Related]

  • 3. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B, Goharderakhshan R, Chang J, Ribeiro-Filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R.
    J Urol; 2001 Sep 01; 166(3):1088-92. PubMed ID: 11490304
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 01; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 5. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 6. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK.
    Cancer Res; 1995 May 15; 55(10):2150-7. PubMed ID: 7743516
    [Abstract] [Full Text] [Related]

  • 7. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
    Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA.
    Genes Chromosomes Cancer; 1999 Oct 15; 26(2):171-5. PubMed ID: 10469456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
    Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JC.
    Cancer Res; 1994 Aug 01; 54(15):4003-6. PubMed ID: 8033130
    [Abstract] [Full Text] [Related]

  • 10. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW.
    Genes Chromosomes Cancer; 1996 Sep 01; 17(1):14-20. PubMed ID: 8889502
    [Abstract] [Full Text] [Related]

  • 11. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
    Wilhelm M, Bugert P, Kenck C, Staehler G, Kovacs G.
    Cancer Res; 1995 Nov 15; 55(22):5383-5. PubMed ID: 7585605
    [Abstract] [Full Text] [Related]

  • 12. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 13. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.
    Cancer Res; 1997 Mar 01; 57(5):907-12. PubMed ID: 9041193
    [Abstract] [Full Text] [Related]

  • 14. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1994 Mar 15; 54(6):1422-4. PubMed ID: 8137242
    [Abstract] [Full Text] [Related]

  • 15. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
    Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sidransky D.
    Cancer Res; 1994 May 01; 54(9):2322-6. PubMed ID: 8162574
    [Abstract] [Full Text] [Related]

  • 16. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA, Groenfeld LE, van der Kwast TH, Zwarthoff EC.
    Br J Cancer; 1999 May 01; 80(3-4):489-94. PubMed ID: 10408858
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM.
    Cancer Res; 1991 Feb 15; 51(4):1071-7. PubMed ID: 1671754
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI.
    Oncogene; 1997 Nov 27; 15(22):2727-33. PubMed ID: 9400999
    [Abstract] [Full Text] [Related]

  • 19. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

  • 20. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S.
    Oncogene; 1999 Jun 24; 18(25):3793-7. PubMed ID: 10391689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.